Centene CEO: We ’re Committed To Buying WellCare
Centene CEO Michael Neidorff is committed to completing the acquisition of WellCare Health Plans with the regulatory process well underway. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - May 7, 2019 Category: Pharmaceuticals Authors: Bruce Japsen, Contributor Source Type: news

How Endologix Renewed One Doctor & #039;s Confidence in the Ovation Device
It's been a turbulent couple of years for Endologix, but as MD+DI reported in February, the company has been working hard to win back customers. During the company's first-quarter earnings call, CEO John Onopchenko shared a story about a physician at an academic medical center in the Western United States (he did not disclose the name of the physician or the center) who had used Ovation only twice over the course of 2017 and 2018.  Irvine, CA-based Endologix acquired the Ovation platform through its merger with TriVascular in February 2016. It's a low-profile device that has broadened the company's portfolio in...
Source: MDDI - May 7, 2019 Category: Medical Devices Authors: Amanda Pedersen Tags: Business Source Type: news

Fresenius Medical Care North America Announces Leadership Additions Following NxStage Merger
New Leadership and Team to Further Company's Commitment to Home Therapies WALTHAM, Mass., May 6, 2019 -- (Healthcare Sales & Marketing Network) -- Fresenius Medical Care North America (FMCNA), the nation's leading provider of kidney care products and s... Devices, Personnel Fresenius, NxStage Medical, dialysis (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 6, 2019 Category: Pharmaceuticals Source Type: news

Centene-WellCare deal scrutinized by American Hospital Association
The American Hospital Association is asking the U.S. Department of Justice to investigate the planned $17.3 billion acquisition of Tampa-based WellCare Health Plans by Clayton-based Centene Corp., saying the transaction threatens to reduce competition. In an April 30 letter to the assistant U.S. attorney general’s AntiTrust Division, the association urged the investigation because the merger is “likely to reduce competition in the provision of Medicaid Services.” Centene Corp. announced… (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - May 6, 2019 Category: American Health Authors: Crystal Owens Source Type: news

WellCare-Centene acquisition scrutinized by American Hospital Association
The American Hospital Association is asking the U.S. Department of Justice to investigate the proposed $17.3 billion acquisition of Tampa-based WellCare Health Plans by Centene Corp., saying the transaction threatens to reduce competition. In an April 30 letter to the Assistant U.S. Attorney General’s AntiTrust Division, the association urged the investigation because the merger is “likely to reduce competition in the provision of Medicaid Services.” Centene Corp. of St. Louis announced… (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - May 6, 2019 Category: American Health Authors: Crystal Owens Source Type: news

Black hole may have swallowed neutron star, say astronomers
Scientists analyse whether gravitational wave detectors picked up signs of collisionAstronomers may havespotted a neutron star being swallowed by a black hole for the first time, marked by a belch of gravitational waves rippling across the cosmos.If confirmed, the detection by the twin Ligo detectors in the US and the Virgo detector in Italy would be the first evidence that black holes and neutron stars can pair up in binary systems. The observations could also reveal new details about the nature of such dramatic mergers, including whether the neutron star was ripped apart before crossing the black hole ’s threshold ...
Source: Guardian Unlimited Science - May 4, 2019 Category: Science Authors: Hannah Devlin Science correspondent Tags: Black holes Space Science World news Source Type: news

Chief nursing officer named for Walker Baptist Medical Center
Walker Baptist Medical Center has named Cindy Key as chief nursing officer. Key has served as interim chief nursing officer since May 2018. She first joined Walker Baptist Medical Center in 2011, following the acquisition of the Alabama Outpatient Surgery Center, where she was manager. She was promoted to director of procedural services and has also held the role of nurs e manager of orthopedics and director of maternal/infant services. Key was also named interim CNO in May 2018.  “Cindy has… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - May 3, 2019 Category: Pharmaceuticals Authors: Tyler Patchen Source Type: news

Chief nursing officer named for Walker Baptist Medical Center
Walker Baptist Medical Center has named Cindy Key as chief nursing officer. Key has served as interim chief nursing officer since May 2018. She first joined Walker Baptist Medical Center in 2011, following the acquisition of the Alabama Outpatient Surgery Center, where she was manager. She was promoted to director of procedural services and has also held the role of nurs e manager of orthopedics and director of maternal/infant services. Key was also named interim CNO in May 2018.  “Cindy has… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - May 3, 2019 Category: Biotechnology Authors: Tyler Patchen Source Type: news

How CareDx Is Bringing AI to Transplant Care
Brisbane, CA-based CareDx has partnered with Cibiltech, a French company that develops artificial intelligence-based products for predictive medicine, to commercialize Predigraft.  Predigraft is a data analysis tool designed to provide an early prediction of a patient's risk of allograft rejection and transplant loss. It was developed from Cibiltech’s software algorithm called iBox, which is built off the outcomes data from tens of thousands of transplant patients. The deal is yet another example of how AI is disrupting the status quo in medtech. MD+DI recently publishe...
Source: MDDI - May 3, 2019 Category: Medical Devices Authors: Amanda Pedersen Tags: Software Source Type: news

Mercy Health parent plans international merger
John Starcher, CEO of Bon Secours Mercy Health, disclosed recently that the U.S. hospital system he oversees from Cincinnati intends to merge with Ireland ’s largest private health care provider. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - May 3, 2019 Category: Pharmaceuticals Authors: Barrett J. Brunsman Source Type: news

Advocate Aurora's one-year checkup: Merger in good health
The CEOs of Milwaukee-based Aurora Health Care and Advocate Health Care in suburban Chicago said it was a merger of equals aimed ultimately at limiting health care cost increases. A one-year checkup shows Advocate Aurora Health Care has made significant strides in coalescing especially at the executive level and has taken steps it believes will “bend the cost curve.” (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - May 3, 2019 Category: Biotechnology Authors: Rich Kirchen Source Type: news

Cigna: Express Scripts Addition Already Brings Patients Quicker Treatment
Cigna said its acquisition of pharmacy benefit manager Express Scripts is bringing quicker treatments to customers while boosting the combined company's profits. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - May 2, 2019 Category: Pharmaceuticals Authors: Bruce Japsen, Contributor Source Type: news

Hospitals: Centene-WellCare Merger Threatens Competition
The American Hospital Association is urging the U.S. Justice Department to take a close look at Centene ’s acquisition of WellCare Health Plans. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - May 2, 2019 Category: Pharmaceuticals Authors: Bruce Japsen, Contributor Source Type: news

Grant Thornton hired to oversee Beth Israel Lahey Health merger
National auditing and advisory firm Grant Thornton will monitor the state ’s largest health care merger in decades between Beth Israel Deaconess Medical Center and Lahey Health. (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - May 2, 2019 Category: American Health Authors: Jessica Bartlett Source Type: news

Smith & Nephew optimistic on full-year sales after acquisition spree 
Hip implant maker signals more says first-quarter revenue rises (Source: FT.com - Drugs and Healthcare)
Source: FT.com - Drugs and Healthcare - May 2, 2019 Category: Pharmaceuticals Source Type: news

LivaNova Disappoints with 1Q19 Earnings
Weak sales from LivaNova’s Neuromodulation business could be one of the main culprits behind the company posting disappointing earnings for 1Q19. The London-based company posted revenues of $250.8 million, vs. the consensus estimate of $255.87 million. As a result, the firm slashed its 2019 outlook. In addition, LivaNova said its 2019 earnings per share came in between $3 and $3.10 vs. the consensus of $3.41. “We are disappointed by our first quarter performance in U.S. Neuromodulation and Perceval sales. As a leadership team, we are implementing a series of actions to counteract the mar...
Source: MDDI - May 2, 2019 Category: Medical Devices Authors: Omar Ford Tags: Business Source Type: news

Practice mergers, super-partnerships and networks - understanding your options
General practices can no longer afford to take a go-it-alone approach if they hope to survive. As the NHS Long Term Plan makes clear, the welcome injection of new money for general practice is conditional on practices being prepared to work at scale. (Source: NHS Networks)
Source: NHS Networks - May 2, 2019 Category: UK Health Source Type: news

AMN Healthcare plans $200M acquisition
AMN Healthcare Services Inc. (NYSE: AMN), which is dual-headquartered in Dallas and San Diego, announced Tuesday the acquisition of a health care staffing company that specializes in placing therapists and nurses in contract positions. Advanced Medical Personnel Services Inc. has about $140 million in revenue and adjusted EBITDA of $20 million. AMN, which is the largest health care staffing company in the country, plans to acquire the company for $200 million with the potential of an additional… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - May 1, 2019 Category: Pharmaceuticals Authors: Staff report Source Type: news

AMN Healthcare plans $200M acquisition
AMN Healthcare Services Inc. (NYSE: AMN), which is dual-headquartered in Dallas and San Diego, announced Tuesday the acquisition of a health care staffing company that specializes in placing therapists and nurses in contract positions. Advanced Medical Personnel Services Inc. has about $140 million in revenue and adjusted EBITDA of $20 million. AMN, which is the largest health care staffing company in the country, plans to acquire the company for $200 million with the potential of an additional… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - May 1, 2019 Category: Biotechnology Authors: Staff report Source Type: news

Caris Life Sciences Acquires Pharmatech
Purchase of leading Just-In-Time clinical trials recruitment service will benefit patients, physicians and drug developers by connecting cancer patients to the right trials faster IRVING, Texas, May 1, 2019 -- (Healthcare Sales & Marketing Network) -- ... Diagnostics, Oncology, Mergers & Acquisitions Caris Life Sciences, Pharmatech, precision medicine (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 1, 2019 Category: Pharmaceuticals Source Type: news

Bayer investors unhappy over Monsanto back management, for now
Large Bayer investors said the company ’s management, including CEO Werner Baumann, should not be removed, despite widespread unhappiness with a drop in share price since its $63 billion acquisition of St. Louis-based Monsanto Co. “A hasty replacement of the CEO would only increase the risk of a break-up and therefore can’t be in the interest of long-term-oriented investors such as Union Investment,” Janne Werning, an analyst at Germany’s Union Investment, a top-20 shareholder, said in… (Source: bizjournals.com Health Care News Headlines)
Source: bizjournals.com Health Care News Headlines - April 29, 2019 Category: Health Management Authors: Greg Edwards Source Type: news

Invitation to Roche Analyst Event at ASCO 2019 - Monday, 3 June 2019
Roche and Spark Therapeutics, Inc. (NASDAQ: ONCE) ( “Spark”) today announced that Roche has withdrawn its Premerger Notification and Report Form under the Hart-Scott-Rodino Act (the “HSR Act”) in connection with Roche’s pending acquisition of Spark pursuant to its previously announced tender offer to purchase all of the outstanding shares o f common stock (the “Shares”) of Spark for USD 114.50 per Share, net to the seller thereof in cash, without interest and subject to any withholding taxes required by applicable law and upon the terms and subject to the conditions set forth in th...
Source: Roche Investor Update - April 29, 2019 Category: Pharmaceuticals Source Type: news

Aratana Therapeutics to be Acquired by Elanco Animal Health
Elanco announces formation of commercial team dedicated to veterinary specialty business LEAWOOD, Kan., April 26, 2019 -- (Healthcare Sales & Marketing Network) -- Aratana Therapeutics (NASDAQ: PETX), a pet therapeutics company focused on developing an... Biopharmaceuticals, Veterinary, Mergers & Acquisitions Aratana Therapeutics, Elanco Animal Health (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - April 26, 2019 Category: Pharmaceuticals Source Type: news

Anthem Ready To Deal No Matter What Happens With Magellan
Anthem executives say the health insurer is well position for acquisitions, including'tuck-in'Medicare Advantage plans. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - April 26, 2019 Category: Pharmaceuticals Authors: Bruce Japsen, Contributor Source Type: news

Waystar's owner reportedly mulling sale of company
Waystar might be the subject of another blockbuster deal. Business publications Bloomberg.com and PEHub.com reported that Boston-based Bain Capital LP, the private equity firm that owns the Louisville-based revenue-cycle management company, is contemplating a strategic option for the company, including the possibility of a sale. Bain Capital acquired W aystar's predecessor, ZirMed Inc., and merged it with Duluth, Ga.-based Navicure Inc. in a $750 million deal in late 2017. The merger led to the… (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - April 26, 2019 Category: American Health Authors: Chris Larson Source Type: news

One of St. Louis' largest architecture firms expands in health care industry with acquisition
CannonDesign has acquired Michigan-based Blue Cottage Consulting to build on the architecture firm's health care portfolio. Officials with CannonDesign said the acquisition will deepen its start-to-finish services, including workflow improvement, on health care projects around the country. While the deal is national in scope, officials said it will impact all of its offices, including St. Louis where health care is amo ng the biggest industries. CannonDesign's existing health care consulting group… (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - April 26, 2019 Category: American Health Authors: Steph Kukuljan Source Type: news

Roche and Spark Therapeutics, Inc. announce withdrawal and refiling of Premerger Notification and Report Form under the HSR Act and extension of tender offer for shares of Spark Therapeutics, Inc.
Roche and Spark Therapeutics, Inc. (NASDAQ: ONCE) ( “Spark”) today announced that Roche has withdrawn its Premerger Notification and Report Form under the Hart-Scott-Rodino Act (the “HSR Act”) in connection with Roche’s pending acquisition of Spark pursuant to its previously announced tender offer to purchase all of the outstanding shares o f common stock (the “Shares”) of Spark for USD 114.50 per Share, net to the seller thereof in cash, without interest and subject to any withholding taxes required by applicable law and upon the terms and subject to the conditions set forth in th...
Source: Roche Media News - April 26, 2019 Category: Pharmaceuticals Source Type: news

Roche and Spark Therapeutics, Inc. announce withdrawal and refiling of Premerger Notification and Report Form under the HSR Act and extension of tender offer for shares of Spark Therapeutics, Inc.
Roche and Spark Therapeutics, Inc. (NASDAQ: ONCE) ( “Spark”) today announced that Roche has withdrawn its Premerger Notification and Report Form under the Hart-Scott-Rodino Act (the “HSR Act”) in connection with Roche’s pending acquisition of Spark pursuant to its previously announced tender offer to purchase all of the outstanding shares o f common stock (the “Shares”) of Spark for USD 114.50 per Share, net to the seller thereof in cash, without interest and subject to any withholding taxes required by applicable law and upon the terms and subject to the conditions set forth in th...
Source: Roche Investor Update - April 26, 2019 Category: Pharmaceuticals Source Type: news

Tencent-backed online healthcare platform Trusted Doctor secures $250M
China's Tencent Trusted Doctor, a venture backed by tech giant Tencent Holdings, announced that it had raised $250M in a fundraising round. The investment was led by Country Garden Holdings, Tencent Holdings and Sequoia Capital, Tencent Trusted Doctor said in a statement. The fundraising marked the first investment since the entity was formed through a merger of Tencent Doctorwork and Trusted Doctors last year. (Source: mobihealthnews)
Source: mobihealthnews - April 26, 2019 Category: Information Technology Source Type: news

3M to Lay Off 2,000 Employees after Weak 1Q19 Earnings
3M is off to a rocky start in 2019 and plans on laying off 2,000 workers. The Maplewood, MN-based company missed consensus and lowered its 2019 earnings forecast. News of the earnings caused shares to drop as much as 10% on Thursday. The firm said it now expects 2019 adjusted earnings to be from $9.25 and $9.75 a share. The prior forecast was from $10.45 to $10.90 per share. Sales were down 5% to $7.9 billion. Organic local-currency sales declined 1.1% while divestitures, net of acquisitions, decreased sales by 0.5%. Foreign currency translation decreased sales by 3.4% year-on-year 3M executives did not sugar coat the comp...
Source: MDDI - April 26, 2019 Category: Medical Devices Authors: Omar Ford Tags: Business Source Type: news

Once fast-rising KC company explores sale after second drug trial failure
Cash-strapped biotech Proteon Therapeutics Inc. is considering a merger or acquisition after shelving its lead kidney disease drug due to a second late-stage clinical trial failure. Proteon (Nasdaq: PRTO) disclosed in a financial filing last week that it does not have enough cash to survive for the next 12 months, with just $22 million left in the bank. In addition to the filing, four members of the company's board of directors resigned last week. Kansas City serial entrepre neur Dr. Nick Franano… (Source: bizjournals.com Health Care News Headlines)
Source: bizjournals.com Health Care News Headlines - April 25, 2019 Category: Health Management Authors: Allison DeAngelis Source Type: news

Once fast-rising KC company explores sale after second drug trial failure
Cash-strapped biotech Proteon Therapeutics Inc. is considering a merger or acquisition after shelving its lead kidney disease drug due to a second late-stage clinical trial failure. Proteon (Nasdaq: PRTO) disclosed in a financial filing last week that it does not have enough cash to survive for the next 12 months, with just $22 million left in the bank. In addition to the filing, four members of the company's board of directors resigned last week. Kansas City serial entrepre neur Dr. Nick Franano… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - April 25, 2019 Category: Biotechnology Authors: Allison DeAngelis Source Type: news

25.04.19: First quarter of 2019:
Bayer: strong operational start to the yearGroup sales increase 4.1 percent (Fx & portfolio adj.) to 13.015 billion euros / EBITDA before special items advances by 44.6 percent to 4.188 billion euros / Crop Science posts substantial sales and earnings gains following the acquisition / Pharmaceuticals shows encouraging sales and earnings growth / Consumer Health below the prior-year quarter, full-year outlook confirmed / Net income declines as expected by 36.5 percent to 1.241 billion euros, held back by special items related to the acquisition and restructuring / Core earnings per share increase 13.8 percent to 2.55 eu...
Source: Bayer IR Newsfeed: Events - April 25, 2019 Category: Pharmaceuticals Source Type: news

14 acquisitions later, Bio-Techne puts the checkbook away as growth unfolds
Charles Kummeth has led Minneapolis-based Bio-Techne Corp. through 14 acquisitions that have transformed the once-quiet firm into a far-reaching enterprise. (Source: bizjournals.com Health Care News Headlines)
Source: bizjournals.com Health Care News Headlines - April 25, 2019 Category: Health Management Authors: Alex Wittenberg Source Type: news

Bayer: strong operational start to the year
Group sales increase 4.1 percent (Fx& portfolio adj.) to 13.015 billion euros / EBITDA before special items advances by 44.6 percent to 4.188 billion euros / Crop Science posts substantial sales and earnings gains following the acquisition / Pharmaceuticals shows encouraging sales and earnings growth / Consumer Health below the prior-year quarter, full-year outlook confirmed / Net income declines as expected by 36.5 percent to 1.241 billion euros, held back by special items related to the acquisition and restructuring / Core earnings per share increase 13.8 percent to 2.55 euros / Business outlook for 2019 confirmed (S...
Source: Bayer Company News - April 25, 2019 Category: Pharmaceuticals Source Type: news

Boston Sci Ends TAVR ‘Duopoly’ Held by Medtronic and Edwards
Edwards Lifesciences and Medtronic are no longer the only two companies with an FDA-approved transcatheter aortic valve replacement device. Boston Scientific has now received a nod from FDA for the Lotus Edge. Lotus Edge might be one of the most watched products in the Marlborough, MA-based company’s pipeline. The device has drawn interest from the medical and Wall Street analyst communities because the current generation of the valve, Lotus, is known for having low rates of paravalvular leak (PVL). The Lotus Edge has been described as being designed to maintain those low PVL rates while also reducing per...
Source: MDDI - April 24, 2019 Category: Medical Devices Authors: Omar Ford Tags: Cardiovascular Source Type: news

Cannabis Operators To Create National Brands Through M & A
Companies expected to roll up operations across state lines. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - April 24, 2019 Category: Pharmaceuticals Authors: Mergermarket, Contributor Source Type: news

Centene says acquisition, state expansions drove 40% quarterly revenue increase
Centene Corp. (NYSE: CNC) on Tuesday credited its first-quarter revenue increase to program expansions in Illinois, Florida and other states, along with its acquisition of Fidelis Care last year. (Source: bizjournals.com Health Care News Headlines)
Source: bizjournals.com Health Care News Headlines - April 23, 2019 Category: Health Management Authors: Brian Robbins Source Type: news

Centene ’s Obamacare Enrollment Soars As WellCare Deal Faces Regulators
Centene's profits from Obamacare and Medicaid continue to soar as it enters the regulatory process for its merger with WellCare Health Plans. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - April 23, 2019 Category: Pharmaceuticals Authors: Bruce Japsen, Contributor Source Type: news

Tampa health care technology service acquires Jacksonville company
HealthAxis Group, a Tampa-based health technology service, has acquired a Jacksonville firm that develops and implements data warehouse and business intelligence solutions. Terms of the acquisition of Analytics Partners were not disclosed. The merger of the companies business operations adds “robust and proven analytics to complement the HealthAxis Group's current and powerful core platform and services,” according to a statement from HealthAxis. HealthAxis Gr oup acquired Analytics Partners’… (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - April 19, 2019 Category: American Health Authors: Crystal Owens Source Type: news

Tampa health care technology service acquires Jacksonville company
HealthAxis Group, a Tampa-based health technology service, has acquired a Jacksonville firm that develops and implements data warehouse and business intelligence solutions. Terms of the acquisition of Analytics Partners were not disclosed. The merger of the companies business operations adds “robust and proven analytics to complement the HealthAxis Group's current and powerful core platform and services,” according to a statement from HealthAxis. HealthAxis Gr oup acquired Analytics Partners’… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - April 19, 2019 Category: Biotechnology Authors: Crystal Owens Source Type: news

Intuitive Falls Short of Expectations in 1Q19
Intuitive Surgical’s momentum was dulled a bit last week when the surgical robotics company missed Wall Street expectations for 1Q19. The miss caused shares of the Sunnyvale, CA-based company to drop by about 6.2%. Intuitive’s revenue came in at about $973.7 million for the quarter, with analysts forecasting $980 million in 1Q19 sales. The company also posted earnings of $2.61 per share, on an adjusted basis. Earnings grew 7% but decelerated from 20% growth in the fourth quarter. The earnings also lagged the consensus of analysts polled by analysts for $2.70. One of the companyâ...
Source: MDDI - April 19, 2019 Category: Medical Devices Authors: Omar Ford Tags: Business Source Type: news

Proteon exploring sale after 2nd drug trial failure
Cash-strapped biotech Proteon Therapeutics is considering a merger or acquisition after shelving its lead kidney disease drug due to a second late-stage clinical trial failure. Waltham-based Proteon (Nasdaq: PRTO) disclosed in a financial filing this week that it does not have enough cash to survive for the next 12 months, with just $22 million left in the bank. Four members of the company's board of directors further resigned this week. It will be laying off an undisc losed amount of its 17 employees… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - April 19, 2019 Category: Biotechnology Authors: Allison DeAngelis Source Type: news

Abbott Has Midas Touch with Its 1Q19 Earnings
Abbott Laboratories is off to a solid start in 2019 if its most recent earnings are any indication. The Abbott Park, IL-based company reported earnings that topped its own forecast. The firm posted first-quarter earnings from continuing operations of 63 cents per share, above the 61 cents expected by analysts, on $7.5 billion in sales. "We're right on track with our expectations to start the year," said Miles White, chairman and CEO, Abbott, said in a release. "All of our key long-term growth drivers are performing well and we're targeting another year of strong sales and earnings growth." Join us for N...
Source: MDDI - April 17, 2019 Category: Medical Devices Authors: Omar Ford Tags: Business Source Type: news

Eritrea: Cervical Cancer Prevention and Control Program Implementation in Eritrea
[WHO] Cervical cancer occurs when the cells of the cervix grow abnormally and invade other tissues and organs of the body. When it is invasive, this cancer affects the deeper tissues of the cervix and may have spread to other parts of the body. Cervical cancer is caused through acquisition of HPV virus (Human Papillomavirus) when a woman is sexually active and the virus has been acquired. Some women then develop pre cancer lesions but in about 66% to 70% of these women, the body normally clears it away. However, (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - April 17, 2019 Category: African Health Source Type: news

UnitedHealth: DaVita Medical Deal ‘Progressing’ On Path To Close
UnitedHealth Group CEO David Wichmann says the insurer has a " clear path to approval " in closing the $4.3 billion acquisition of DaVita Medical Group. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - April 17, 2019 Category: Pharmaceuticals Authors: Bruce Japsen, Contributor Source Type: news

Able & Co. Celebrates Tenth Year With Spacious New Location and...
Expertise in marketing for mergers, acquisitions, and franchises fuels growth(PRWeb April 17, 2019)Read the full story at https://www.prweb.com/releases/able_co_celebrates_tenth_year_with_spacious_new_location_and_expanded_staff/prweb16102646.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - April 17, 2019 Category: Pharmaceuticals Source Type: news

Lawsuits Put a Drag on J & amp;J 1Q19 Earnings
Legal costs surrounding Johnson and Johnson’s talc baby power and its blood thinner Xarleto bogged down the healthcare giant’s 1Q19 earnings. But while earnings from the New Brunswick, NJ-based company were down 14% from a year earlier, the firm managed to beat analyst expectations. J&J posted income of $3.75 billion or $1.39 per share for 1Q19. In 1Q18, the company brought in $4.37 billion or $1.60 per share. As a result, the healthcare company changed its full-year earnings forecast to a range of $8.53 to $8.63 a share, down from its previous estimate of between $8.50 and $8.65. Th...
Source: MDDI - April 16, 2019 Category: Medical Devices Authors: Omar Ford Tags: Business Source Type: news

Biotech with large Triangle presence buying Maryland firm for $1.2B
Catalent Inc., a New Jersey-based contract drug manufacturer with a large Triangle presence, said Monday it will acquire Maryland's Paragon Bioservices Inc. for $1.2 billion. Catalent (NYSE: CTLTC) will fund the acquisition using the proceeds of a $650 million incremental term loan from JPMorgan Chase Bank, as well as the issuance of $650 million of new convertible preferred stock to Leonard Green& Partners L.P. Peter Zippelius, a partner at LGP, will join Catalent ’s board of directors as part… (Source: bizjournals.com Health Care News Headlines)
Source: bizjournals.com Health Care News Headlines - April 16, 2019 Category: Health Management Authors: Morgan Eichensehr Source Type: news

Patch Offers a New Approach for Treating Iron Deficiency
Patch-like wearables are becoming increasingly popular in medtech. The latest device to employ such a design and make medtech headlines is transdermal patch being developed by Fe3 Medical. San Antonio, TX-based Fe3 said its biphasic iontophoretic transdermal technology is for the treatment of iron deficiency anemia. The firm announced results from its first human study of the patch-like device. The human study focused on the safety and tolerability of Fe3's iontophoretic transdermal technology designed to bypass ionic resistance build up in the skin. The human study follows a series of successful preclinical studies demons...
Source: MDDI - April 15, 2019 Category: Medical Devices Authors: Omar Ford Tags: Adhesives Source Type: news